On 2026-05-07, MBX Biosciences, Inc. (MBX) announced earnings per share of $-0.51 for the fiscal quarter ending 2026-03-31, beating the average analyst estimate of $-0.62.
The next expected annoucement date for quarterly earnings is 2026-08-06, with an average estimated earnings per share of $-0.66 for the fiscal quarter ending 2026-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2026-05-07 | 2026-03-31 | $-0.62 | $-0.51 |
| 2026-03-12 | 2025-12-31 | $-0.64 | $-0.49 |
| 2025-11-06 | 2025-09-30 | $-0.73 | $-0.63 |
| 2025-08-07 | 2025-06-30 | $-0.77 | $-0.58 |
| 2025-05-12 | 2025-03-31 | $-0.81 | $-0.71 |
| 2025-03-17 | 2024-12-31 | $-0.59 | $-0.47 |
| 2024-11-07 | 2024-09-30 | $-2.72 | $-2.78 |